Over 7500 new entries added to your top-notch resource for disease-associated germline mutations​ The HGMD Professional 2024.4 release sees 7618...

While artificial intelligence for variant classification can analyze massive data sets, it lacks the human insight needed for complex, nuanced...

The industry-leading database for germline mutations adds over 7,900 new expert-curated entries with the HGMD Professional 2024.3 release. HGMD Professional...

As clinical labs face increasing demands to analyze complex immune repertoires, accurate and efficient software tools have become essential. CLC...

Over 430 new clinical trials, 50 new therapies, and 9 new fully curated clinically significant somatic genes included in the...

Over 9,000 disease-associated germline mutations have been added to the industry-leading database HGMD Professional 2024. 2 is now available, adding...

The latest QCI Interpret 2024 Release enhances performance of high-throughput NGS labs, improving turn-around time, diagnostic yield and quality of...

Featuring new data from 15 fully curated genes, 497 clinical trials and more A new release for COSMIC Actionability is...

It has been 20 years since COSMIC was first launched, yet our journey to fully understanding cancer genes is far...

QIAGEN launches QCI Secondary Analysis, a new cloud-based secondary analysis solution for oncology and inherited disease applications that enables high-throughput...